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Abstract
Initiation is the rate-limiting phase of protein synthesis, controlled by signaling pathways regulating the phosphorylation of
translation factors. Initiation has three steps, 43S, 48S and 80S formation. 43S formation is repressed by eIF2a
phosphorylation. The subsequent steps, 48S and 80S formation are enabled by growth factors. 48S relies on eIF4E-mediated
assembly of eIF4F complex; 4E-BPs competitively displace eIF4E from eIF4F. Two pathways control eIF4F: 1) mTORc1
phosphorylates and inactivates 4E-BPs, leading to eIF4F formation; 2) the Ras-Mnk cascade phosphorylates eIF4E. We show
that REN and NCI-H28 mesothelioma cells have constitutive activation of both pathways and maximal translation rate, in the
absence of exogenous growth factors. Translation is rapidly abrogated by phosphorylation of eIF2a. Surprisingly,
pharmacological inhibition of mTORc1 leads to the complete dephosphorylation of downstream targets, without changes in
methionine incorporation. In addition, the combined administration of mTORc1 and MAPK/Mnk inhibitors has no additive
effect. The inhibition of both mTORc1 and mTORc2 does not affect the metabolic rate. In spite of this, mTORc1 inhibition
reduces eIF4F complex formation, and depresses translocation of TOP mRNAs on polysomes. Downregulation of eIF4E and
overexpression of 4E-BP1 induce rapamycin sensitivity, suggesting that disruption of eIF4F complex, due to eIF4E
modulation, competes with its recycling to ribosomes. These data suggest the existence of a dynamic equilibrium in which
eIF4F is not essential for all mRNAs and is not displaced from translated mRNAs, before recycling to the next.
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Introduction
Extracellular signals control the translational machinery, induc-
ing phosphorylation and changes in the activity of translation
factors. However, the rapidity by which the translational machinery
responds to extracellular signaling, regulating rate and mRNA
selection has not been systematically addressed. Initiation of
translation is the rate-limiting step of translation, and is controlled
by initiation factors (IF) [1,2]. Three steps are required.
1) Formation of 43S through the recruitment of the ternary
complex, formed by eIF2-GTP-tRNA(i)Met, on the small 40S
ribosomal subunit. Inhibition of eIF2 activity is mediated by
phosphorylation of eIF2a subunit by either one of four eIF2a
kinases, PERK, Gcn2, HRK, PKR switched on by several
conditions, including ER stress, aminoacid deprivation, lack of
heme, double strand RNA [3,4]. The net result of eIF2a
phosphorylation is a block in general initiation. However, specific
ORFs, which are silenced in conditions of high levels of ternary
complex because they lie downstream of short upstream ORFs
(uORFs), are translated upon eIF2a phosphorylation [5].
2) Formation of 48S after the binding of mRNA complexed to
eIF4F, and scanning to the AUG start codon. The 59 end of
mRNA binds 43S, mediated by eIF4F. eIF4F is a multiprotein
complex: initiation factors eIF4E, eIF4G, and eIF4A assemble on
the m7Gppp cap structure [6]. 4E-binding proteins (4E-BPs) are
inhibitory factors preventing eIF4F formation by binding eIF4E
and replacing eIF4G [7]. Growth factor activation controls eIF4F
assembly [1]. In response to growth factors, 4E-BPs are hyper-
phosphorylated, and released from eIF4E [8], allowing eIF4G
recruitment on eIF4E. Although the bulk of translation is cap-
dependent and stimulated by eIF4F, some mRNAs do not require
eIF4F activity, and can be translated in conditions of impaired
translation [9]. Examples are represented by IRES-mediated
translation, in which an Internal Ribosome Entry Site mediates
the direct attachment of the ribosome in the absence of eIF4F
[10,11].
In principle, eIF4F assembly depends from signaling pathways.
Prominently, the phosphoinositide 3-kinase (PI3K) signaling
pathway, one of the most frequently deregulated oncogenic
pathways, converges on the serine/threonine kinase Akt, and to
the mammalian target of rapamycin (mTOR) kinase [12,13]. The
mTOR kinase assembles with either Raptor or Rictor to generate
two distinct complexes, mTOR complex 1 and 2 (mTORc1 and
mTORc2), respectively. The most known translational regulators
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phosphorylated by mTORc1, are eIF4E binding proteins 4E-BP1,
4E-BP2, and 4E-BP3 (4E-BPs) and ribosomal protein S6 kinase
p70 (S6k1). The result of 4E-BPs phosphorylation is increasing
eIF4F activity due to the lack of eIF4E repression. In addition,
activation of the Ras pathway leads to the phosphorylation and
activation of MAP-interacting kinases-1/2 (Mnk1 or Mnk2), which
in turn phosphorylate eIF4E [14,15]. Although the exact
mechanism by which eIF4E phosphorylation affects translation
is unclear, it may increase affinity of eIF4E for the mRNA cap
structure and for eIF4G. The mTORc1 pathway is efficiently
inhibited by rapamycin and its analogues. Recently, others and we
described the relative insensitivity of several cancer cell lines and
patients to the action of rapalogues; the insensitivity was linked to
mutations in the Ras pathway [16]. In line with this, we suggested
the presence of rapamycin insensitive translational regulation
stimulated by PKC [17] or by adhesion to extracellular matrix
[18]. Others reported that rapamycin does not inhibit translation
recovery after hypertonic stress [19]. These observations raised the
question on how different signaling pathways operate on the
translational machinery, whether they are redundant or whether
they may be dispensable.
3) The third regulating step of initiation is the formation of
elongating 80S, upon recruitment of free 60S subunits and release
of eIF2, assisted by eIF5B [20]. Little is understood about
regulation of 80S formation. eIF6 plays an important role in
maintaining free 60S ribosomal subunits [21,22], downstream of
the growth factor stimulated pathways [23]. eIF6 depletion results
in impaired translation, upon insulin stimulation [24].
To further dissect the signaling pathways leading to transla-
tional machinery regulation, we screened for cells where the
mTORc1 and Ras/ERK pathways were active and studied the
effect of their inhibition on translation. We focused on short term
treatment with inhibitors, in order to analyze direct effects on the
translational machinery. We found that in REN and NCI-H28 cell
lines, initiation of translation was insensitive to the treatment with
mTOR inhibitor, with exception for translation of TOP mRNAs.
Sensitivity to inhibition of the mTORc1 pathway could be
reestablished only by 4E-BP1 expression or eIF4E downregula-
tion. These data lead to a model in which the rate of rapamycin
sensitivity can be regulated transcriptionally. The lack of effects on
global translation by short term inhibition of the main pathways
suggests that initiation factors can recycle to a new mRNA
efficiently without being regulated by mTORc1 or Ras signaling.
Results
Translation of REN cells is growth factors independent
and is abrogated by eIF2a phosphorylation
We screened for cell lines with constitutively activated mTOR-
Akt pathway in order to test the hypothesis that activated
pathways lead to deregulated translation, which can be targeted
by pharmacological treatment. We found a malignant mesothe-
lioma cell line REN, able to grow under starving conditions that
was further characterized. Most mesothelioma cells [25] respond
to insulin/IGF-I by increasing protein synthesis, as measured by
methionine incorporation. REN cells were serum starved and
methionine incorporation was measured in either insulin stimu-
lated or unstimulated cells. Methionine incorporation was not
significantly affected by insulin stimulation (Fig. 1A). In starved
cells, methionine incorporation was reduced to 10% by cyclohex-
imide treatment, that blocks elongation, indicating that it was due
to active protein synthesis (Fig. 1A).
Mesothelioma cells are actively secreting cells [26] and may be
susceptible to ER stress. In contrast to the insensitivity to growth
factor deprivation, REN cells were highly susceptible to mem-
brane stress. Administration of thapsigargin (Tg) [27], dithiothre-
itol (DTT), which are ER stress inducing drugs, or arsenite (As)
[28] lead to eIF2a phosphorylation (Fig. 1B and Fig. S1A) and
Figure 1. Translation rate is insensitive to exogenous growth
factors but sensitive to ER stress. (A) REN cells were starved
overnight of growth factors. Cells were treated with 50 nM insulin (INS),
with 50 mg/ml cycloheximide (CHX) or left untreated and pulsed with
35S-methionine for 45 minutes. Methionine incorporation in newly
translated proteins was measured in triplicate. Insulin does not increase
translation in REN cells. (B) REN cells were starved overnight of growth
factors. Cells were treated with 100 mM arsenite (As), 10 mM
dithiothreitol (DTT), 2 mM thapsigargin (Tg) or 10 mg/ml brefeldin A
(BrefA) for 45 minutes and total proteins were extracted. Total extracts
were analyzed in WB to test eIF2a phosphorylation. Densitometric
analysis of phospo-eIF2a normalized to total eIF2a is reported. (C) REN
cells were starved overnight of growth factors. Cells were treated as
indicated and pulsed with 35S-methionine. Methionine incorporation in
newly translated proteins was measured in triplicate. Arsenite,
dithiothreitol and thapsigargin block translation in REN cells.
doi:10.1371/journal.pone.0029136.g001
Effect of Rapamycin Treatment in REN Cells
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block of methionine incorporation (Fig. 1C). Brefeldin A, which
inhibits protein transport from ER to Golgi [29] causes a minor
eIF2a phosphorylation after short treatment, which is not
sufficient to block the translation rate. In these conditions eIF2a
phosphorylation does not lead to caspase 3 activation (Fig. S1B).
Taken together, these data indicate that REN cells are highly
sensitive to ER stress-induced block of protein synthesis, i.e. 43S
formation, but are independent from growth factor stimulation.
These data suggest that REN cells have constitutive activation of
the growth-factor activated pathways, and translation should be
repressed by inhibiting signaling pathways.
Short-term inhibition of mTOR does not affect initiation
and methionine incorporation
Two main pathways transduce the growth factor stimulation to
the translational machinery: PI3K-mTORc1 and Ras-MAPK-Mnk.
These two pathways are always deregulated in solid tumors, and
converge on the translational machinery (Fig. 2A). We wanted to
evaluate if either one, or both of them, can regulate translation in
these cells. REN were treated with kinase inhibitors: mTORc1
inhibitor rapamycin, MEK inhibitor U0126, Mnk1 inhibitor 4-
Amino-5-(4-fluoroanilino)-pyrazolo[3,4-d]pyrimidine. Analysis of
phosphorylation of downstream targets was performed. In basal
conditions we found that mTORc1 targets 4E-BP1 and rpS6, Mnk1
target eIF4E, and Ras target ERK1/2 were all phosphorylated.
These results are in agreement with the observation that stimulation
of REN cells with insulin does not lead to increased methionine
incorporation. Treatment with rapamycin resulted in dephosphor-
ylation of 4E-BP1 and rpS6, suggesting the complete switch off of the
signaling cascade. U0126 treatment abrogated ERK1/2 phosphor-
ylation downstream of MEK kinase. The inhibition of Mnk1
abrogated phosphorylation of downstream target eIF4E (Fig. 2B). In
contrast with the efficient dephosphorylation of all targets after
treatment with these drugs, only a minimal drop of translation rate
was measured by methionine incorporation (Fig. 2C).
It has been reported that mTORc1 inactivation by rapamycin
results in a feedback activation of ERK1/2 [30]. In agreement
with this, REN cells treated with rapamycin showed increased
eIF4E and ERK1/2 phosphorylation (Fig. 2B). Thus, we
hypothesized that the simultaneous inhibition of MAPK and
mTORc1, could abrogate phosphorylation of downstream targets
and result in a decrease in methionine incorporation. Coadmin-
istration of rapamycin and U0126 led to the complete dephos-
phorylation of ERK1/2, but not of eIF4E. However we did not
observe an additive reduction in methionine incorporation
(Fig. 2C). p38 MAPK remained phosphorylated with all
treatments (not shown) and may account for the residual eIF4E
phosphorylation [31].
Figure 2. Translation rate is largely insensitive to the efficient
inhibition of mTORc1. (A) Scheme of major linear pathways
regulating translation. (B) REN cells were treated for 45 minutes with
50 nM rapamycin (RAPA), 10 mM U0126, 5 mM 4-Amino-5-(4-fluoroani-
lino)-pyrazolo[3,4-d]pyrimidine (Mnk1 inhib.) as indicated and total
proteins were extracted. Total extracts were analyzed by WB to test
activity of mTORc1, ERK1/2 and Mnk1 signaling. Rapamycin blocks
mTORc1 activity, preventing 4E-BP1 and rpS6 phosphorylation. U0126
inhibits MEK, preventing phosphorylation of downstream targets ERK1/
2, Mnk1 and eIF4E. Mnk1 inhibitor 4-Amino-5-(4-fluoroanilino)-pyra-
zolo[3,4-d]pyrimidine blocks eIF4E phosphorylation. (C) REN cells were
treated as indicated and pulsed with 35S-methionine. Methionine
incorporation in newly translated proteins was measured in triplicate.
mTOR, ERK1/2, or Mnk1 inactivation minimally reduce translation. Even
combination of multiple drugs, in order to switch off multiple signaling
pathways, has no additive effect on reducing protein synthesis.
doi:10.1371/journal.pone.0029136.g002
Effect of Rapamycin Treatment in REN Cells
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It is established that rapamycin blocks mTORc1 complex, but
not mTORc2 complex. mTORc2 phosphorylates Akt, account-
ing for the activation of a pathway that may impinge on survival
and on the translational machinery [32]. mTOR kinase
inhibition was performed with PP242, an inhibitor that targets
the ATP binding domain, blocking both mTORc1 and mTORc2
signalling [33]. We treated cells with PP242 and tested the
phosphorylation of mTORc1 and mTORCc2 downstream
effectors. 4E-BP1, rpS6 and Akt were dephosphorylated.
(Fig. 3A). Then we measured methionine incorporation in REN
cells treated with different concentration of PP242, both at the
EC50 of the compound and 100 times more concentrated.
Surprisingly, methionine incorporation was unaffected by PP242
treatment (Fig. 3B).
These data indicate that in REN cells translation rates are
insensitive to the inhibition of growth factor signaling pathways.
Inhibition of mTOR changes the turnover of mRNA
classes on ribosomes
A known readout of growth factor stimulation is the assembly
of the cap complex, which is dependent on mTOR signaling.
Data in Figure 4A show that mTORc1 inhibition by rapamycin
causes an enrichment of 4E-BP1 bound to eIF4E which
displaces the binding to eIF4G i.e. inhibition of cap complex
formation. The effect of Mnk/MAPK inhibition was subtle;
U0126 did not affect 4E-BP1 binding to eIF4E, but caused a
minimal decrease of eIF4G binding (Fig. 4B). mTORc1 and
mTORc2 inhibition by PP242 strongly affects the cap complex
assembly of initiation factors (Fig. 4C). It follows that i) since this
disruption is not accompanied by a decrease in methionine
incorporation, other factors may be rate-limiting, ii) at least
some mRNAs may be affected by cap complex inhibition, but
not by MAPK inhibition.
Thus, we asked whether inhibition of mTORc1 and MAPK
signaling affected translation of specific mRNAs. Polysomal
profiles of cells treated with inhibitors showed small changes in
80S/polysomal ratio, confirming the minimal reduction of
initiation when the pathways are blocked (Fig. 5). Fraction from
polysomes were then collected and analyzed by Northern Blot to
analyze the distribution of translated mRNAs. We focused on
TOP mRNAs that encode for ribosomal proteins and a number of
translation factors, because they are strongly dependent from
mTOR signaling [34]. Briefly, we found a slight decrease in
polysomal distribution of TOP mRNA in cells treated with
rapamycin and PP242 (Fig. 5), suggesting that the translation of
this class of mRNAs is specifically sensitive to 4E-BP1 bound to
eIF4E, disrupting the cap complex. The levels of TOP mRNA
translation remained however fairly high, indicating that most
mRNAs escaped the inhibition of eIF4F formation. Taken
together, data suggest that even upon inhibition of 4E-BP1
phosphorylation, sufficient eIF4E is present in the cell to guarantee
proper initiation. However, the composition of translated mRNAs
changes upon inhibition of the mTOR pathway.
Restoring rapamycin sensitivity through transcriptional
modulation of eIF4F factors
We then asked what is the rate-limiting event of cap
dependent translation of REN cells. Thus, we formulated the
hypothesis that 4E-BP1 is not sufficient to sequestrate eIF4E.
REN cells were infected with adenovirus overexpressing 4E-
BP1 wt, 4E-BP1 LM/AA, protein mutant unable to bind eIF4E
[35], or adenoviral construct alone. The levels of overexpressed
proteins were detected by WB (Fig. 6A). Then we analyzed the
methionine incorporation both in basal conditions and upon
rapamycin administration. We found that the level of transla-
tion in cells overexpressing 4E-BP1 wt, was reduced after
rapamycin treatment. Control adenovirus infected cells, cells
overexpressing 4E-BP1 LM/AA or cells overexpressing rapa-
mycin insensitive mutation (4Ala) [36] were not affected by
rapamycin treatment (Fig. 6B and Fig. S2A). The overexpres-
sion of 4E-BP1 wt or mutated did not affect caspase 3 activation
(Fig. S2B).
Next, we downregulated eIF4E, by interfering with specific
siRNA. Downregulation was confirmed by western blot (Fig. 6C
and Fig. S2C and D) and rapamycin sensitive translation was
monitored. mTOR inhibition induces a reduction of global
translation in cells with lower eIF4E levels (Fig. 6D). Caspase 3
activation was not affected by eIF4E levels (Fig. S2D).
Figure 3. PP242 does not affect translation rate. (A) REN cells were treated with rapamycin or with PP242 and total proteins were extracted.
Total extracts were analyzed in WB to test activity of mTORc1 and mTORc2 signaling. PP242 blocks both rpS6 and 4E-BP1 phosphorylation by
mTORc1 and Akt phosphorylation by mTORc2. (B) REN cells were treated as indicated and pulsed with 35S-methionine. Global translation was
measured in triplicate. mTOR kinase inactivation does not reduce translation.
doi:10.1371/journal.pone.0029136.g003
Effect of Rapamycin Treatment in REN Cells
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So far we have shown that REN cells have an impairment of
cap complex formation, but not global reduction of translation,
upon mTOR inhibition. Next we evaluated whether this
phenomenon is present in other cells. Global translation of
ME-180 cells, that have constitutively activated PI3K [37], is
sensitive to rapamycin inhibition ([16] and Fig. 7). Similarly, in
mesMM98, that have less expression of eIF4E as compared to
REN cells (Fig. S3), protein synthesis is sensitive to rapamycin
treatment. It has been reported that p53 can downregulate the
level of 4E-BP1 and eIF4G [38] and transcriptionally reduce the
level of c-myc [39], thus we selected a mesothelioma cell line
(NCI-H28) with wt p53 [40]. Surprisingly NCI-H28 cells were
not sensitive to rapamycin inhibition of translation (Fig. 7 and
8E). Thus we focused on the characterization of the pathways
regulating translation in these cells. First, eIF2a phosphorylation
induced by ER stress, caused inhibition of translation (Fig. 8A
and B). Next, the pharmacological block of mTORc1, MEK
and Mnk1 caused the dephosphorylation of downstream targets
(Fig. 8C). However, as for the REN cells, also in NCI-H28 the
complete block of the mTORc1 pathway impaired the cap
complex assembly (Fig. 8D), without any significative effect on
the global translation (Fig. 8E). Even the administration of
PP242 did not reduce translation at a significative level (Fig. 8F
and G).
Here we conclude that cap complex inhibition does not match
the global translation, and that global translation is not necessarily
reduced by mTOR inhibition in all cellular types.
Discussion
We show that in the absence of 4E-BP1 overexpression or
eIF4E downregulation, the efficient pharmacological inhibition of
mTOR pathway does not change, in short term, the efficiency of
the translational apparatus. These data indicate that part of the
regulation of translation rate, at least in REN cells, may occur
transcriptionally through the abundance of eIF4E. In addition,
rapamycin does not depress translation, in spite of reducing cap
complex formation. It follows that, in vivo, at steady-state recycling
of eIF4E from a processed mRNA to a new preinitiation complex
is either kinetically or sterically favored respect to binding of eIF4E
to 4E-BP.
Translational control is becoming an attractive target in cancer
cells [41]. However, we need to further understand the complex
ways by which the process of transformation can perturb the
translational machinery. REN mesothelioma cells, here charac-
terized, are able to survive and proliferate under growth factor and
matrix deprivation, giving rise to metastatic cancer in experimen-
tal models [26,42]. We characterized translational control in REN
mesothelioma cells in the absence of exogenous stimulation, in
order to establish the relevance of endogenous pathways
Figure 4. The cap complex formation is inhibited by mTOR
inactivation. (A) REN cells were treated as indicated and total proteins
were incubated with 7-Methyl GTP-Sepharose beads. Input is 10% of the
purification. Cap binding proteins were analyzed by WB with anti-4E-BP1
and with anti-eIF4G. eIF4E shows equal amount of purified proteins.
Rapamycin treatment induces 4E-BP1 binding to eIF4E and eIF4G is
displaced from the complex. Densitometric analysis of eIF4G levels
normalized to eIF4E are reported. (B) Densitometric analysis of eIF4G
levels normalized to eIF4E, from 5 independent experiments are
reported. (C) REN cells were treated as indicated and total proteins were
incubated with 7-Methyl GTP-Sepharose beads. Input is 5% of the
purification. Cap binding proteins were analyzed by WB with anti-4E-BP1
and with anti-eIF4G. eIF4E shows equal amount of purified proteins.
doi:10.1371/journal.pone.0029136.g004
Effect of Rapamycin Treatment in REN Cells
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converging on translation. Malignant mesothelioma is a slow
growing tumor resistant to chemotherapy [43]. Here, we report
that the metabolic rate of REN cells is not only independent from
exogenous growth factor activation, but also largely insensitive to
the inhibition of both mTOR and MAPK pathways, suggesting
that it is controlled by transcriptional activation of the ribosomal
machinery. We observed similar results in NCI-H28, but not in
mesMM98 mesothelioma cells.
The transcriptional regulation of initiation factors is an emerging
concept, that is becoming relevant in cancer research [44]. Myc is
known to regulate the translational machinery [45,46] and,
specifically, it regulates eIF4E and eIF4G levels [47,48]. Myc also
stimulates the output of Pol I [49] and Pol III [50], resulting in the
increase of rRNA and tRNA expression. It remains to be established
if also 4E-BP1 is under the control of Myc oncogene. REN cells
express more c-myc than mesMM98 in line with their rapamycin
insensitivity. It has to be established with future work if a causative
relation between c-myc expression and eIF4E exists in mesotheli-
oma cells. P53 has been reported to regulate eIF4G and 4E-BP1
[39]. We could not establish a relationship between p53 and
rapamycin sensitivity. A more intriguing possibility exists: it was
recently shown that mTOR inactivation in the heart led to 4E-BP
upregulation [51]. If this is a general case, one contribution of the
constitutively active PI3K-mTOR pathway on the translational
control, is the stimulation of eIF4F formation by the transcriptional
repression of one key player, 4E-BPs, through yet unknown
mechanisms. Thus, in cancer cells, cap complex activation may
result from three separate routes: inactivation of 4E-BPs by
phosphorylation, upregulation of eIF4E and transcriptional down-
regulation of 4E-BP1. These three elements may not be exclusive.
The marginal effect of the inhibition of signaling pathways on
the translational machinery can reflect the fact that we employed
short-term treatments. This led to an interesting observation: the
temporal disjunction between the efficient inhibition of the
pathway and the effect on translational machinery. First, we
found that in REN cells rapamycin treatment blocked mTOR
dependent assembly of cap complex, without a significative
reduction of metabolic rate. Moreover, when we blocked TOR
kinase activity with PP242, leading to a complete inhibition of
both mTORc1 and mTORc2, even at 100 mM, where PP242 has
been reported to aspecifically block PI3K/Akt pathway [33], the
global rate of translation was not affected, after short term
treatment. We previously found that the sensitivity of the
translational apparatus to pharmacological inhibition with Ever-
olimus, a rapamycin analogue, was linked to mutations in the Ras
pathway [16]. The MAPK-ERK signaling pathway, downstream
of Ras, acts on the initiation of translation, at least at three levels:
Mnk1/2 phosphorylate eIF4E at Ser 209, and this event
contributes to malignancy [52]; rpS6 is phosphorylated by p90
Ribosomal S6 Kinases [53]; 4E-BP1 has rapamycin insensitive,
serum dependent phosphorylation sites [54]. Even if ERK1/2
was constitutively activated in REN cells, the inhibition of either
this pathway trough U0126 drug or Mnk1 inhibition, had a
modest role on the general level of translation. In addition, the
combination of multiple inhibiting drugs was not effective.
Finally, when we performed long-term treatment with rapamy-
cin, we were able to reduce cap dependent translation (Grosso,
unpublished data). Taken together, these observations are
consistent with two interpretations, which are not mutually
exclusive: 1) the kinetics of inhibition of eIF4E by 4E-BP1 in vivo,
is delayed, indicating that eIF4E actively engaged in eIF4F,
recycles to the mRNA, rather than binding to free 4E-BPs. This
interpretation is backed up by the observation that increasing 4E-
BP1 or lowering eIF4E results in a more rapid inhibition of
translation by rapamycin; 2) in principle, oncogenic activation by
Ras, PI3K or Myc may alter by a transcriptional mechanism the
sensitivity of the translational machinery to pharmacological
inhibition.
An early event observed after rapamycin treatment is the
decrease of translation of TOP mRNAs. This indicates that TOP
mRNA translation is highly sensitive to cap complex inhibition as
shown in several laboratories (reviewed in [34]). The fact that at
the same time the metabolic rate is not yet altered can be due to
two reasons: 1) the reduction in TOP mRNA translation is
Figure 5. TOP mRNA translation is inhibited by mTOR
inactivation. REN cells were treated as indicated and total extracts
were loaded on sucrose gradient. Polysomal profiles were performed,
fractions from the gradient were collected and RNA was precipitated.
Northern Blot analysis of rpL7 (TOP) and b-Actin mRNAs were
performed. Polysomal profiles confirm that blocking mTOR and MAPK
signaling has no effect on global translation. Rapamycin and PP242
displace TOP messengers from polysomes. PMP indicates the percent-
age of rpL7 mRNA associated to polysomes.
doi:10.1371/journal.pone.0029136.g005
Effect of Rapamycin Treatment in REN Cells
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marginal with respect to global protein synthesis and below the
sensistivity of our assay, 2) in early phases of inhibition, TOP
mRNAs are competitively replaced by other classes of mRNAs
that have a reduced requirement for the cap complex. It remains
to be established which are the mRNAs that replace TOP on the
translating ribosomes. Attractive candidates are IRES containing
mRNA that can be translated independently from eIF4F
complex [55]. Whatever the mechanism at play, these data
strengthen the importance of the regulation of the translational
machinery in cell cycle progression, since a continuous feed from
the growth factor signaling pathway is required for the synthesis
of new ribosomes.
In consideration of the data that we presented, showing that
inhibition of signaling pathways may not always affect translation of
cancer cells, it may be more fruitful to directly inhibit the association
of initiation factors. Recently, it was reported that 4EGI-1, a
compound that disrupts eIF4E/eIF4G association, inhibits cap-
dependent translation [56]. In this context, also hippuristanol has
been reported to block eIF4A helicase activity reducing the
translation of structured mRNAs [57], and ribavirin affects the
eIF4E localization in the cytoplasm [58], without acting as mimic of
mRNA cap structure [59]. It will be interesting to investigate
whether REN cells are also insensitive to these compounds.
Materials and Methods
Cell Lines and Culture
The following human Malignant Mesothelioma cell lines were
used: REN cells, inflammatory epithelial subtype [60]; NCI-H28
(CRL5820), epithelial subtype was purchased from the American
Figure 6. 4E-BP1 overexpression or eIF4E reduction restore rapamycin sensitivity. (A) REN cells were infected with myc tagged-4E-BP1 WT,
LM/AA (unable to bind eIF4E) or with control adenovirus with the indicated Multiple of Infection (m.o.i.). WT and LM/AA HA-4E-BP1 expression was
confirmed by WB analysis of the myc tag. Exogenous 4E-BP1 is expressed as the same level as the endogenous protein. Serine 65 phosphorilation of
4E-BP1 is reduced by rapamycin treatment, as expected. (B) Infected cells were treated with rapamycin or left untreated and pulsed with 35S-
methionine. Methionine incorporation in newly translated proteins was measured in triplicate. WT 4E-BP1 overexpression restores the rapamycin
sensitivity in REN cells. (C) REN cells were transfected with eIF4E siRNA or control. After 48 hrs, total protein were analyzed by WB in order to measure
eIF4E downregulation. Densitometric analysis of eIF4E level normalized to b-Actin is reported. (D) REN cells were transfected with eIF4E siRNA or
control. Cells were treated with rapamycin and the rate of translation was measured. Rapamycin impairs translation where eIF4E level is reduced.
doi:10.1371/journal.pone.0029136.g006
Figure 7. Rapamycin treatment has no effect on global protein
synthesis in two epithelial malignant mesothelioma cell lines.
REN (epithelial malignant mesothelioma), NCI-H28 (epithelial malignant
mesothelioma), mesMM98 (sarcomatoid malignant mesothelioma) and
ME-180 (cervical carcinoma) cells were treated with rapamycin and
pulsed with 35S-methionine. Global translation was measured in
triplicate, normalized on total protein content. The level of translation
of untreated cells is set to 100%. Rapamycin reduces translation in
mesMM98 and ME-180 cell lines, but it is ineffective on REN and NCI-H28.
doi:10.1371/journal.pone.0029136.g007
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Type Culture Collection (ATCC); MesMM98 cells, established
from pleural effusion of a sarcomatous mesothelioma [61]. ME-
180 cells from endometrial cancer, were purchased from the
American Type Culture Collection (ATCC). REN and mesMM98
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM); NCI-H28 and ME-180 cells were cultured in
RPMI1640. Media were purchased by Lonza, and supplemented
with 10% fetal bovine serum (FBS) (from Euroclone) and 1%
glutamine and antibiotic mixture (from Gibco).
Drugs and Reagents
Insulin (human, recombinant), cycloheximide, MEK inhibitor
U0126 and mTOR inhibitor PP242 were from Sigma. RNasinH
was from Promega. Mnk1 inhibitor 4-Amino-5-(4-fluoroanilino)-
pyrazolo[3,4-d]pyrimidine and mTORc1 inhibitor rapamycin were
purchased from Calbiochem. All other chemicals were from Sigma.
Methionine Labeling
Cells were pulsed with 33 mCi per plate of Promix 35S-labeled
methionine (PerkinElmer Life Sciences) for 45 min, in the tested
conditions. Cells were lysed in 50 ml of RIPA buffer without SDS
(10 mM Tris–HCl, pH 7.5, 1% Na-deoxycholate, 1% Triton X-
100, 150 mM NaCl, 1 mM EDTA, protease inhibitor cocktail
from Sigma). The lysate was cleared by centrifugation. Aliquots of
10 ml of extracts were TCA-precipitated and counted with
scintillation fluid in a b-counter (Packard). Values were normalized
on sample protein content by the bicinchoninic acid (BCA) protein
assay (Pierce). Each sample was performed in triplicate and
expressed as mean6 SEM. Statistical analysis was performed with
T Student test. * is P,0.05. ** is P,0.01.
Western blotting
Cells were lysed with buffer containing 10 mM NaCl, 10 mM
MgCl2, 10 mM Tris–HCl, pH 7.3, 1% Triton X-100, 1% Na-
deoxycholate, 1 mM DTT, 5 mM NaF, 2 mM Na3VO4, 40 U/
ml RNasinH (Promega), protease inhibitor cocktail. The crude cell
extract was clarified at 4uC at 15,000g for 10 min and the amount
of protein in the supernatant was quantified by the bicinchoninic
acid (BCA) protein assay. Equal amount of proteins was analyzed.
Extracts were resolved on SDS–PAGE, transferred to Immobilon-
P membranes (Millipore), and probed with appropriate antibodies.
The following antibodies were used: rabbit anti-phospho-eIF2a
(Ser 51), anti-eIF2a, anti-phospho-4E-BP1 (Ser 65), anti-4E-BP1,
anti-phospho-rpS6 (Ser 235/236), anti-rpS6, anti-phospho-p44/
42 MAPK (ERK1/2) (Thr 202/Tyr204), anti-p44/42 MAPK
(ERK1/2), anti-phospho-eIF4E (Ser 209), anti-eIF4E, anti-phos-
pho-Mnk1 (Thr 197/202), anti-Mnk1, anti-phospho-Akt (Ser 473),
anti-Akt, anti-eIF4G and anti-c-myc from Cell Signaling; mouse
anti-b Actin from Sigma; mouse anti Caspase 3 from Alexis.
Densitometric analysis was performed by ImageQuant 5.0
software (Molecular Dynamics).
m7GTP Cap Column Pull-Down
Cap column pull-down was performed on 400 mg of total
extracts as described [62].
Polysomal Profiles and Northern Blot
Polysomal profiles were performed as previously described [63],
with some modifications. . Cells (1–26106) that had been washed
once with phosphate-buffered saline buffer (150 mM NaCl,
2.7 mM KCl, 8 mM NaH2PO4 and 1.4 mM K2PO4), were lysed
directly on the plate with 300 ml of lysis buffer (10 mM NaCl,
10 mM MgCl2, 10 mM Tris-HCl pH 7.5, 1% triton-X100, 1%
sodiun deoxycholate, 36 U/ml RNase inhibitor, 1 mM dithio-
threitol) and transferred into a microcentrifuge tube. After 5 min
of incubation in ice with occasional vortexing, the lysate was
centrifuged for 10 min at 10,000 rpm (15,000 g) at 4uC. The
supernatant was frozen in liquid nitrogen and stored at 270uC to
be analyzed later, or immediately layered in a 15–50% (w/v)
sucrose gradient containing 30 mM Tris-HCl pH 7.5, 100 mM
NaCl and 10 mM MgCl2, and centrifuged in a Beckman SW41
rotor for 110 min at 37,000 rpm (170,000 g).
Analysis of the polysome/mRNP distribution of mRNAs were
performed essentially as previously described [64]. In particular,
polysomal fractions were collected while monitoring the optical
density at 254 nm and total RNA was extracted from each fraction
by the proteinase K method. For Northern analysis, RNA was
fractionated on formaldehyde-agarose gels and transferred to
GeneScreen Plus membrane (PerkinElmer Life Sciences). North-
ern blotting was performed essentially as recommended by the
manufacturer. Radioactive probes were prepared by the random
primer technique using gel purified cDNA fragments. Quantita-
tion of Northern blots was performed using a PhosphorImager and
the Image-Quant software (Amersham).
Adenoviral and retroviral infections
Adenovirus: Lac Z control, 4E-BP1 WT and 4E-BP1 LM/AA,
were a kind gift of Pr C. Proud. Virus stock were amplified and
titer were determinated using Adeno-X TM rapid titer kit (ref
PT3651-2; Clontech). Multiplication of infection (M.O.I) of 50 for
4E-BP1 WT and of 100 for 4E-BP1 LM/AA and control LacZ
were used (as reported in [35]). Retrovirus: pBABE-puro, 4E-BP1
WT and 4E-BP1 4Ala were kind gift of Pr N. Sonenberg. Infection
was carried out as previously described [36].
siRNA (small interfering RNA) transfection
The siRNA targeted to human eIF4E was purchased from
Ambion. The sequence is as follows: siRNA ID #4578,
Figure 8. In malignant mesothelioma cell line NCI-H28, mTOR inhibition blocks the formation of the cap complex, without affecting
the ongoing translation. (A) NCI-H28 cells were treated with 2 mM thapsigargin (Tg) and total proteins were extracted. Extracts were analyzed by
WB to test eIF2a phosphorylation. (B) NCI-H28 cells were treated as indicated and for 45 minutes and pulsed with 35S-methionine. Methionine
incorporation in newly translated proteins was measured in triplicate. Thapsigargin blocks translation in NCI-H28 cells (C) Cells were treated for
45 minutes with 50 nM rapamycin (RAPA), 10 mM U0126, 5 mM 4-Amino-5-(4-fluoroanilino)-pyrazolo[3,4-d]pyrimidine (Mnk1 inhib.) as indicated and
total proteins were extracted. Total extracts were analyzed by WB to test activity of mTORc1, ERK1/2 and Mnk1 signaling. Rapamycin blocks mTORc1
activity. (D) NCI-H28 cells were treated as indicated and total proteins were incubated with 7-Methyl GTP-Sepharose beads. Input is 10% of the
purification. Cap binding proteins were analyzed by WB with anti-4E-BP1 and with anti-eIF4G. eIF4E shows equal amount of purified proteins. (E) Cells
were treated as indicated and pulsed with 35S-methionine. Methionine incorporation in newly translated proteins was measured in triplicate. mTORc1
inactivation does not reduce translation. (F) Cells were treated with rapamycin or with PP242 and total proteins were extracted. Extracts were
analyzed by WB to test activity of mTORc1 and mTORc2 signaling. PP242 blocks both rpS6 and 4E-BP1 phosphorylation by mTORc1 and Akt
phosphorylation by mTORc2. (G) Cells were treated as indicated and pulsed with 35S-methionine. Global translation was measured in triplicate. mTOR
kinase inactivation reduces translation only at 1 mM concentration.
doi:10.1371/journal.pone.0029136.g008
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59-GGUAUACAAGGAAAGGUUAtt-39 (sense) and 59-UAAC-
CUUUCCUUGUAUACCct-39 (antisense). Identical not shown
results were obtained with siRNA ID #4577, 59-GCUAAUUA-
CAUUGAACAAAtt-39 (sense) and 59-UUUGUUCAAU-
GUAAUUAGCca-39 (antisense). The negative control siRNA was
purchased from Ambion (negative control siRNA #1).
REN cells (1.56105) were seeded per plate (35 mm diameter)
the day before transfection. Cells were transfected with 20 nM
oligonucleotide using N-TERTM Nanoparticle siRNA Transfec-
tion System (Sigma) according to manufacturer protocol. Protein
expression was assessed by Western blotting at 48 h post-
transfection and densitometric analysis was performed. A
metabolic assay was carried out at 48 h post-transfection as
described above.
Supporting Information
Figure S1 ER stress inducing drugs do not cause
Caspase 3 activation at the analyzed time point. (A)
Densitometric analysis of phospho-eIF2a normalized to total
eIF2a after thapsigargin (Tg) treatment is reported from four
independent experiments. (B) Total extracts from figure 1B were
analyzed in WB to test activation of Caspase 3. On the left panel, a
positive control for activated caspase 3 is shown.
(TIF)
Figure S2 ER stress inducing drugs do not cause
Caspase 3 activation at the analyzed timepoint. (A)
REN cells were infected with HA-4E-BP1 WT, 4Ala (unable to
be phosphorylated) or with empty control retrovirus pBABE.
Infected cells were treated with rapamycin and pulsed with 35S-
methionine. Methionine incorporation in newly translated pro-
teins was measured in triplicate. 4Ala-4E-BP1 transfected cells are
unable to sense the rapamycin treatment. (B) REN cells extracts
from figure 6A were analyzed in WB to test Caspase 3 activation.
(C) REN cells were transfected with eIF4E siRNA at 10 nM or
20 nM concentrations. After 48 hrs, total proteins were analyzed
by WB in order to measure eIF4E downregulation. A good
downregulation of eIF4E protein was obtained at 50 nM siRNA
concentration. (D) REN cells were transfected with eIF4E siRNA
or control. After 48 hrs, cells were treated with rapamycin and
total proteins were analyzed by WB to test eIF4E reduction and
Caspase 3 activation.
(TIF)
Figure S3 C-Myc and initiation factors protein expres-
sion in REN and mesMM98 cell lines. Total protein extract
from malignant mesothelioma cell lines REN and mesMM98 were
analyzed with WB for eIF4E, eIF4G, 4E-BP1 and c-Myc protein
expression. Densitometric analysis of eIF4E, eIF4G, 4E-BP1 and
c-Myc levels normalized to b-Actin are reported. REN cell express
more c-Myc and eIF4E proteins.
(TIF)
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